Emerging therapeutic targets for Gaucher disease.

Abstract excerpt

INTRODUCTION: Gaucher disease (GD) is an inherited metabolic disorder caused by mutations in the glucocerebrosidase (GBA1) gene. Although infusions of recombinant GBA ameliorate the systemic effects of GD, this therapy has no effect on the neurological manifestations. Patients with the neuronopathic forms of GD (nGD) are often severely disabled and die prematurely. The search for innovative drugs is thus urgent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Design
• Share to Gaucher Disease
• Share to Glucosylceramidase